Status:

UNKNOWN

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

Lead Sponsor:

Washington Neuropsychology Research Group

Collaborating Sponsors:

Genzyme, a Sanofi Company

Conditions:

Relapsing Remitting Multiple Sclerosis

Eligibility:

All Genders

25-50 years

Brief Summary

People with multiple sclerosis (MS) often experience problems with cognitive functioning, which can be debilitating and interfere with their daily functioning. However, research has shown that MS dise...

Detailed Description

The current will use a neuropsychological evaluation capable of detecting the broad range of cognitive difficulties associated with relapsing remitting MS (RRMS). It is a sub-study of an investigation...

Eligibility Criteria

Inclusion

  • Diagnosis of relapsing remitting MS and enrollment in Care-MS II trial
  • Non-MS controls must be neurologically healthy (with respect to conditions that impact CNS functioning).
  • Participants must be between the ages of 25 and 50.
  • Corrected vision of subjects must be no worse than 20/50.
  • Participants must have at least 10 years of education.
  • Participants must be capable of writing and pressing the buttons on a computer mouse.
  • Participants must be capable of understanding and following all test instructions.

Exclusion

  • Participants with a history of head injury, seizures, or neurological conditions involving the central nervous system (other than MS for the MS groups).
  • Participants with upper extremity dysfunction which prohibits them from using a computer mouse.
  • Participants who are colorblind.
  • Participants with history of psychosis or other severe mental illness.
  • Participants with current alcohol/substance abuse.
  • Participants taking medications with potential adverse CNS effects

Key Trial Info

Start Date :

March 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT00914758

Start Date

March 1 2009

End Date

December 1 2011

Last Update

June 5 2009

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

The Research and Education Institute of Alta Bates Summit Medical Center

Berkely, California, United States, 94705

2

Associates In Neurology. PSC

Lexington, Kentucky, United States, 40513

3

Springfield Neurology Associates, LLC

Springfield, Massachusetts, United States, 01104

4

Dartmouth Medical School/Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States, 03756

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS) | DecenTrialz